Literature DB >> 17577298

What can epidemiology tell us about systemic lupus erythematosus?

J F Simard1, K H Costenbader.   

Abstract

Systemic lupus erythematosus (SLE) is an often-severe autoimmune rheumatic disease most commonly diagnosed in women in their childbearing years. It is thought to develop when genetically predisposed individuals are exposed to one or more environmental triggers. This review outlines the epidemiologic evidence for several putative risk factors including cigarette smoke, hormonal and reproductive factors, environmental silica and infectious exposures, as well as many yet to be identified. We also review the evidence for factors associated with increased disease activity and adverse outcomes in SLE. We review the literature on the epidemiology of SLE, its distribution, potential risk factors for its onset and for adverse outcomes. The information considered in this review was gathered through extensive review of the literature. Online Pubmed literature searches, previous reviews of the epidemiology of SLE and original studies were employed. Epidemiologic studies have helped to identify some of these potential risk factors, including exogenous hormone use, cigarette smoking, infections such as Epstein-Barr virus (EBV) and crystalline silica exposure, but many more have yet to be studied. These exposures may interact with multiple genetic factors in determining susceptibility to SLE. While epidemiologic research has contributed an enormous amount to our understanding of the disease and its pathogenesis, there are many more avenues of epidemiologic research that deserve to be pursued.

Entities:  

Mesh:

Year:  2007        PMID: 17577298     DOI: 10.1111/j.1742-1241.2007.01434.x

Source DB:  PubMed          Journal:  Int J Clin Pract        ISSN: 1368-5031            Impact factor:   2.503


  22 in total

Review 1.  Epidemiology research in rheumatology-progress and pitfalls.

Authors:  Deborah P M Symmons
Journal:  Nat Rev Rheumatol       Date:  2015-07-07       Impact factor: 20.543

Review 2.  Modulation of autoimmune rheumatic diseases by oestrogen and progesterone.

Authors:  Grant C Hughes; Divaker Choubey
Journal:  Nat Rev Rheumatol       Date:  2014-08-26       Impact factor: 20.543

3.  Influence of Alcohol Consumption on the Risk of Systemic Lupus Erythematosus Among Women in the Nurses' Health Study Cohorts.

Authors:  Medha Barbhaiya; Bing Lu; Jeffrey A Sparks; Susan Malspeis; Shun-Chiao Chang; Elizabeth W Karlson; Karen H Costenbader
Journal:  Arthritis Care Res (Hoboken)       Date:  2017-03       Impact factor: 4.794

4.  Resistin levels in lupus and associations with disease-specific measures, insulin resistance, and coronary calcification.

Authors:  Joshua F Baker; Megan Morales; Mohammed Qatanani; Andrew Cucchiara; Eleni Nackos; Mitchell A Lazar; Karen Teff; Joan Marie von Feldt
Journal:  J Rheumatol       Date:  2011-09-01       Impact factor: 4.666

Review 5.  Genetics, environment, and gene-environment interactions in the development of systemic rheumatic diseases.

Authors:  Jeffrey A Sparks; Karen H Costenbader
Journal:  Rheum Dis Clin North Am       Date:  2014-09-02       Impact factor: 2.670

6.  Mycoplasmal lipid-associated membrane proteins and Mycoplasma arthritidis mitogen recognition by serum antibodies from patients with rheumatoid arthritis.

Authors:  Hermínio M da Rocha Sobrinho; Renata Jarach; Nilzio A da Silva; Marina T Shio; Sonia Jancar; Jorge Timenetsky; Milton A P Oliveira; Miriam L Dorta; Fátima Ribeiro-Dias
Journal:  Rheumatol Int       Date:  2010-10-30       Impact factor: 2.631

Review 7.  Understanding the role of environmental factors in the development of systemic lupus erythematosus.

Authors:  Christine G Parks; Aline de Souza Espindola Santos; Medha Barbhaiya; Karen H Costenbader
Journal:  Best Pract Res Clin Rheumatol       Date:  2017-10-21       Impact factor: 4.098

8.  Illness Identity in Adults with a Chronic Illness.

Authors:  Leen Oris; Koen Luyckx; Jessica Rassart; Liesbet Goubert; Eva Goossens; Silke Apers; Seher Arat; Joris Vandenberghe; René Westhovens; Philip Moons
Journal:  J Clin Psychol Med Settings       Date:  2018-12

9.  IFN regulatory factor 5 is required for disease development in the FcgammaRIIB-/-Yaa and FcgammaRIIB-/- mouse models of systemic lupus erythematosus.

Authors:  Christophe Richez; Kei Yasuda; Ramon G Bonegio; Amanda A Watkins; Tamar Aprahamian; Patricia Busto; Rocco J Richards; Chih Long Liu; Regina Cheung; Paul J Utz; Ann Marshak-Rothstein; Ian R Rifkin
Journal:  J Immunol       Date:  2009-12-09       Impact factor: 5.422

10.  Functional polymorphisms of folate-metabolizing enzymes in relation to homocysteine concentrations in systemic lupus erythematosus.

Authors:  Carolyn M Summers; Andrew J Cucchiara; Eleni Nackos; Andrea L Hammons; Elisabeth Mohr; Alexander S Whitehead; Joan M Von Feldt
Journal:  J Rheumatol       Date:  2008-09-01       Impact factor: 4.666

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.